Two Acquisitions in One Day: OpenAI Buys 'Narrative', Anthropic Buys 'Barriers'
On April 2, OpenAI and Anthropic each announced an acquisition, reflecting their divergent strategies as both target an IPO by late 2026. OpenAI acquired tech talk show TBPN to shape public AI discourse and support its revenue base, which is 60% consumer-driven from ChatGPT subscriptions. In contrast, Anthropic purchased AI biotech startup Coefficient Bio for approximately $400 million in stock, continuing its focused strategy of deepening enterprise capabilities, particularly in high-switching-cost sectors like life sciences.
Over the past three years, OpenAI completed 15 acquisitions across diverse fields including hardware, media, and healthcare, spending over $7.7 billion on disclosed deals, such as the $6.5 billion purchase of Jony Ive’s AI hardware firm. Anthropic made only three acquisitions, each precisely strengthening its product stack: Bun for coding infrastructure, Vercept for autonomous agents, and now Coefficient Bio for biotech R&D pipelines.
Anthropic’s enterprise-focused revenue (80% of total) drives its strategy to lock in clients with vertical integration, as seen in its sequenced moves into life sciences and healthcare. Meanwhile, with a higher reliance on consumer subscriptions, OpenAI is investing in narrative influence—TBPN aims to boost ad revenue and steer public AI conversation.
Both companies are on accelerated IPO paths: Anthropic eyeing a $60+ billion offering led by Goldman Sachs and JPMorgan, and OpenAI targeting a ~$1 trillion valuation. Their acquisitions underscore distinct priorities—Anthropic builds industry-specific moats, while OpenAI amplifies its public story.
marsbit04/03 10:07
